Festival of Books
Everything you need to know about the Festival of Books

Topics

Leveraged Buyouts
Ackman, Valeant partner in bid to buy Botox maker Allergan
Ackman, Valeant partner in bid to buy Botox maker Allergan

Activist investor Bill Ackman is partnering with a Canadian pharmaceutical company in an effort to buy Allergan Inc., the Irvine company that makes the popular wrinkle treatment Botox. Ackman and Valeant Pharmaceuticals International Inc. have already acquired nearly 10% of Allergan's shares and will soon offer to purchase the company, Ackman and Valeant said Monday in a regulatory filing. News of the likely bid increased the stock price of both companies. In after-hours trading, investors drove up Allergan as much as 21% and Valeant by 10%. No formal offer was made Monday, but there was speculation about how much Allergan could fetch. The company's stock closed Monday at...

Loading